{
    "pmcid": "10231691",
    "qa_pairs": {
        "What are the advantages of using plant systems for producing recombinant proteins, as highlighted in the study?": [
            "Scalability, safety, and cost-effectiveness",
            "High yield, rapid growth, and genetic stability",
            "Resistance to pests, drought tolerance, and high biomass",
            "Nutrient efficiency, low water usage, and environmental adaptability"
        ],
        "What is the primary target for nanobody binding in the context of SARS-CoV-2?": [
            "The receptor-binding domain (RBD) on the S1 subunit of the spike protein",
            "The nucleocapsid protein of the virus",
            "The membrane protein of the virus",
            "The envelope protein of the virus"
        ],
        "What method was used to confirm the binding affinity of plant-derived VHH antibodies to the SARS-CoV-2 spike protein?": [
            "ELISA assays",
            "Flow cytometry",
            "Mass spectrometry",
            "Surface plasmon resonance"
        ],
        "What potential delivery method for VHH antibodies is suggested to enhance efficacy against respiratory infections like COVID-19?": [
            "Inhalation delivery",
            "Oral delivery",
            "Intravenous injection",
            "Topical application"
        ],
        "Which plant was used to produce VHH antibodies in the study?": [
            "Transgenic tobacco plants",
            "Transgenic corn plants",
            "Transgenic soybean plants",
            "Transgenic rice plants"
        ]
    }
}